Filana Therapeutics, Inc. Stock-Based Compensation
Filana Therapeutics, Inc. (FLNA) reported Stock-Based Compensation of $4.07 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-05-07
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $4.07M, a 22.12% decline year-over-year.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.37M, a 6.44% decline year-over-year.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.40M, a 21.50% decline year-over-year.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $4.58M, a 75.92% increase year-over-year.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $19.58M, a 20.20% increase from fiscal 2024.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $16.29M, a 255.23% increase from fiscal 2023.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $4.59M, a 121.97% increase from fiscal 2022.
- Filana Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.07M, a 17.45% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $4.07M 10-Q · filed 2026-05-07 | $9.44M derived: sum of 2 quarters · filed 2026-05-07 | $13.85M derived: sum of 3 quarters · filed 2026-05-07 | $18.43M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.78M derived: sum of 2 quarters · filed 2026-03-12 | $14.36M derived: sum of 3 quarters · filed 2026-03-12 | $19.58M 10-K · filed 2026-03-12 |
| 2025-09-30 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $8.98M derived: sum of 2 quarters · filed 2025-11-12 | $14.21M 10-Q · filed 2025-11-12 | $19.95M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.81M 10-Q · filed 2025-08-14 | $15.55M derived: sum of 3 quarters · filed 2026-05-07 | $21.16M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | $5.22M 10-Q · filed 2026-05-07 | $10.97M derived: sum of 2 quarters · filed 2026-05-07 | $16.58M derived: sum of 3 quarters · filed 2026-05-07 | $19.18M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $11.35M derived: sum of 2 quarters · filed 2026-03-12 | $13.96M derived: sum of 3 quarters · filed 2026-03-12 | $16.29M 10-K · filed 2026-03-12 |
| 2024-09-30 | $5.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $8.21M derived: sum of 2 quarters · filed 2025-11-12 | $10.55M 10-Q · filed 2025-11-12 | $12.68M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.94M 10-Q · filed 2025-08-14 | $7.07M derived: sum of 3 quarters · filed 2026-03-12 | $8.02M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $2.33M 10-Q · filed 2025-05-08 | $4.46M derived: sum of 2 quarters · filed 2026-03-12 | $5.41M derived: sum of 3 quarters · filed 2026-03-12 | $6.25M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.08M derived: sum of 2 quarters · filed 2026-03-12 | $3.91M derived: sum of 3 quarters · filed 2026-03-12 | $4.59M 10-K · filed 2026-03-12 |
| 2023-09-30 | $949.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.78M derived: sum of 2 quarters · filed 2024-11-07 | $2.46M 10-Q · filed 2024-11-07 | $3.07M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.51M 10-Q · filed 2024-08-08 | $2.12M derived: sum of 3 quarters · filed 2025-03-03 | $2.59M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $673.00K 10-Q · filed 2024-05-10 | $1.29M derived: sum of 2 quarters · filed 2025-03-03 | $1.76M derived: sum of 3 quarters · filed 2025-03-03 | $2.24M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.09M derived: sum of 2 quarters · filed 2025-03-03 | $1.57M derived: sum of 3 quarters · filed 2025-03-03 | $2.07M 10-K · filed 2025-03-03 |
| 2022-09-30 | $470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $955.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.45M 10-Q · filed 2023-11-07 | $1.97M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $980.00K 10-Q · filed 2023-08-03 | $1.50M derived: sum of 3 quarters · filed 2024-02-28 | $2.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $495.00K 10-Q · filed 2023-05-01 | $1.02M derived: sum of 2 quarters · filed 2024-02-28 | $1.59M derived: sum of 3 quarters · filed 2024-02-28 | $2.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.09M derived: sum of 2 quarters · filed 2024-02-28 | $1.51M derived: sum of 3 quarters · filed 2024-02-28 | $1.76M 10-K · filed 2024-02-28 |
| 2021-09-30 | $572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $987.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.24M 10-Q · filed 2022-11-07 | $1.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $665.00K 10-Q · filed 2022-08-04 | $903.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $250.00K 10-Q · filed 2022-05-05 | $488.00K derived: sum of 2 quarters · filed 2023-02-28 | $716.00K derived: sum of 3 quarters · filed 2023-02-28 | $968.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $466.00K derived: sum of 2 quarters · filed 2023-02-28 | $718.00K derived: sum of 3 quarters · filed 2023-02-28 | $988.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $480.00K derived: sum of 2 quarters · filed 2021-11-15 | $750.00K 10-Q · filed 2021-11-15 | $1.05M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $522.00K 10-Q · filed 2021-08-04 | $826.00K derived: sum of 3 quarters · filed 2021-08-04 | $1.15M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $270.00K 10-Q · filed 2021-04-29 | $574.00K derived: sum of 2 quarters · filed 2021-04-29 | $893.00K derived: sum of 3 quarters · filed 2021-04-29 | $1.22M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $623.00K derived: sum of 2 quarters · filed 2021-03-23 | $952.00K derived: sum of 3 quarters · filed 2021-03-23 | $1.30M 10-K · filed 2021-03-23 |
| 2019-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $648.00K derived: sum of 2 quarters · filed 2020-11-09 | $992.00K 10-Q · filed 2020-11-09 | $1.40M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $673.00K 10-Q · filed 2020-08-12 | $1.08M derived: sum of 3 quarters · filed 2020-08-12 | $1.56M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $344.00K 10-Q · filed 2020-05-06 | $747.00K derived: sum of 2 quarters · filed 2020-05-06 | $1.23M derived: sum of 3 quarters · filed 2020-05-06 | $1.93M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $887.00K derived: sum of 2 quarters · filed 2020-03-26 | $1.59M derived: sum of 3 quarters · filed 2020-03-26 | $2.39M 10-K · filed 2020-03-26 |
| 2018-09-30 | $484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $1.18M derived: sum of 2 quarters · filed 2019-10-29 | $1.99M 10-Q · filed 2019-10-29 | $2.73M derived: sum of 4 quarters · filed 2019-10-29 |
| 2018-06-30 | $699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $1.50M 10-Q · filed 2019-08-12 | $2.25M derived: sum of 3 quarters · filed 2019-08-12 | $2.94M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $802.00K 10-Q · filed 2019-05-02 | $1.55M derived: sum of 2 quarters · filed 2019-05-02 | $2.24M derived: sum of 3 quarters · filed 2019-05-02 | $2.95M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.44M derived: sum of 2 quarters · filed 2019-03-29 | $2.15M derived: sum of 3 quarters · filed 2019-03-29 | $2.97M 10-K · filed 2019-03-29 |
| 2017-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $1.40M derived: sum of 2 quarters · filed 2018-10-30 | $2.22M 10-Q · filed 2018-10-30 | $3.07M derived: sum of 4 quarters · filed 2018-10-30 |
| 2017-06-30 | $709.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $1.54M 10-Q · filed 2018-07-26 | $2.38M derived: sum of 3 quarters · filed 2018-07-26 | $3.23M derived: sum of 4 quarters · filed 2018-07-26 |
| 2017-03-31 | $827.00K 10-Q · filed 2018-05-09 | $1.67M derived: sum of 2 quarters · filed 2018-05-09 | $2.52M derived: sum of 3 quarters · filed 2018-05-09 | $3.45M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $845.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-06 | $1.69M derived: sum of 2 quarters · filed 2018-02-06 | $2.62M derived: sum of 3 quarters · filed 2018-02-06 | $4.33M 10-K · filed 2018-02-06 |
| 2016-09-30 | $845.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.78M derived: sum of 2 quarters · filed 2017-11-01 | $3.49M 10-Q · filed 2017-11-01 | $4.31M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | $934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.64M 10-Q · filed 2017-08-09 | $3.46M derived: sum of 3 quarters · filed 2017-08-09 | $4.26M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $1.71M 10-Q · filed 2017-04-26 | $2.53M derived: sum of 2 quarters · filed 2017-04-26 | $3.32M derived: sum of 3 quarters · filed 2017-04-26 | $4.20M derived: sum of 4 quarters · filed 2017-04-26 |
| 2015-12-31 | $818.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $1.61M derived: sum of 2 quarters · filed 2017-03-07 | $2.49M derived: sum of 3 quarters · filed 2017-03-07 | $3.46M 10-K · filed 2017-03-07 |
| 2015-09-30 | $795.00K 10-Q · filed 2015-11-09 | $1.68M derived: sum of 2 quarters · filed 2015-11-09 | $2.64M 10-Q · filed 2016-10-26 | $3.64M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | $881.00K 10-Q · filed 2015-07-23 | $1.84M 10-Q · filed 2016-07-19 | $2.85M derived: sum of 3 quarters · filed 2017-03-07 | $3.94M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-03-31 | $962.00K 10-Q · filed 2016-05-05 | $1.97M derived: sum of 2 quarters · filed 2017-03-07 | $3.06M derived: sum of 3 quarters · filed 2017-03-07 | $3.94M derived: sum of 4 quarters · filed 2017-03-07 |
| 2014-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $2.09M derived: sum of 2 quarters · filed 2017-03-07 | $2.98M derived: sum of 3 quarters · filed 2017-03-07 | $3.76M 10-K · filed 2017-03-07 |
| 2014-09-30 | $1.09M 10-Q · filed 2015-11-09 | $1.97M derived: sum of 2 quarters · filed 2015-11-09 | $2.76M 10-Q · filed 2015-11-09 | $3.53M derived: sum of 4 quarters · filed 2016-03-03 |
| 2014-06-30 | $884.00K 10-Q · filed 2015-07-23 | $1.67M 10-Q · filed 2015-07-23 | $2.44M derived: sum of 3 quarters · filed 2016-03-03 | $3.28M derived: sum of 4 quarters · filed 2016-03-03 |
| 2014-03-31 | $783.00K 10-Q · filed 2015-05-08 | $1.55M derived: sum of 2 quarters · filed 2016-03-03 | $2.39M derived: sum of 3 quarters · filed 2016-03-03 | $3.21M derived: sum of 4 quarters · filed 2016-03-03 |
| 2013-12-31 | $771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.61M derived: sum of 2 quarters · filed 2016-03-03 | $2.42M derived: sum of 3 quarters · filed 2016-03-03 | $3.10M 10-K · filed 2016-03-03 |
| 2013-09-30 | $839.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $1.65M derived: sum of 2 quarters · filed 2014-11-05 | $2.33M 10-Q · filed 2014-11-05 | $4.91M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $812.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $1.49M 10-Q · filed 2014-08-06 | $4.07M derived: sum of 3 quarters · filed 2015-02-18 | $6.33M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $679.00K 10-Q · filed 2014-05-07 | $3.26M derived: sum of 2 quarters · filed 2015-02-18 | $5.51M derived: sum of 3 quarters · filed 2015-02-18 | $6.38M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $4.83M derived: sum of 2 quarters · filed 2015-02-18 | $5.70M derived: sum of 3 quarters · filed 2015-02-18 | $6.61M 10-K · filed 2015-02-18 |
| 2012-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $3.13M derived: sum of 2 quarters · filed 2013-11-01 | $4.03M 10-Q · filed 2013-11-01 | $5.24M derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-06-30 | $869.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $1.78M 10-Q · filed 2013-08-01 | $2.99M derived: sum of 3 quarters · filed 2014-02-05 | $4.48M derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-03-31 | $907.00K 10-Q · filed 2013-04-24 | $2.12M derived: sum of 2 quarters · filed 2014-02-05 | $3.61M derived: sum of 3 quarters · filed 2014-02-05 | $5.03M derived: sum of 4 quarters · filed 2014-02-05 |
| 2011-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-05 | $2.70M derived: sum of 2 quarters · filed 2014-02-05 | $4.13M derived: sum of 3 quarters · filed 2014-02-05 | $5.43M 10-K · filed 2014-02-05 |
| 2011-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.91M derived: sum of 2 quarters · filed 2012-11-09 | $4.22M 10-Q · filed 2012-11-09 | $20.42M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $2.73M 10-Q · filed 2012-08-02 | $18.93M derived: sum of 3 quarters · filed 2013-02-08 | $20.09M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-03-31 | $1.30M 10-Q · filed 2012-05-08 | $17.51M derived: sum of 2 quarters · filed 2013-02-08 | $18.67M derived: sum of 3 quarters · filed 2013-02-08 | |
| 2010-12-31 | $16.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $17.36M derived: sum of 2 quarters · filed 2013-02-08 | $20.13M 10-K · filed 2013-02-08 | |
| 2010-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $3.93M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $2.77M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $6.66M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |